The proposed transaction is expected to deepen cooperation between the companies across group medical and general insurance, subject to the satisfaction of multiple closing conditions.
Insurer's net loss of HK$31m (US$3.96m) in 2025 comes after a profit in 2024, and a recent shift in business mix should help reduce loss exposure, says the ratings agency.
90% decline in net income comes following significant reserve release in 2023 alongside slower topline growth, but Fitch projects profitability to normalise going forward.
